Significance of SALL4 as a drug resistant factor in lung cancer
收藏官方服务：
资源简介：
Significance of SALL4 as a drug resistant factor in lung cancer
应用场景：
创建时间：
2014-04-30
相关数据集
Systems analysis of adaptive responses to MAP Kinase pathway blockade in BRAF mutant melanoma
Fifty percent of cutaneous melanomas are driven by activated BRAFV600E, but tumors treated with RAF inhibitors, even when they respond dramatically, rapidly adapt and develop resistance. Thus, there i
DataONE2020-06-24 更新90
MiRNA expression data from TMZ-resistant GBM cell line
Glioblastoma multiforme(GBM) is the most common and lethal malignant primary brain tumor. Temozolomide (TMZ) is a promising chemo-therapeutic agent to treat GBM. However, resistance to TMZ develops qu
NIAID Data Ecosystem80
Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway
BackgroundThe sustained clinical activity of the BRAF inhibitor vemurafenib (PLX4032/RG7204) in patients with BRAFV600 mutant melanoma is limited primarily by the development of acquired resistance le
Figshare2016-01-18 更新50
Gene expression profiling in carmustine-resistant melanoma A2058 cells
Analysis of gene expression and compare the significant changed genes with associated phenotypes. Total RNA extracted from parental or carmustine-resistant A2058 cells.
NIAID Data Ecosystem80
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition. Homo sapiens
EGFR-mut NSCLC lines show differential suceptibility to inhibition of tankyrase in the presence of EGFR inhibitors Overall design: NSCLC cells were treated in quadruplicate with gefitinib, AZ1366 (tan
NIAID Data Ecosystem80
